Dr. Lee Hamm
Dean, Tulane University School of Medicine | Tulane University
New Orleans, LA, UNITED STATES
Dr. Hamm is an expert on kidney diseases and hypertension
Media
Publications:
Documents:
Videos:
Audio/Podcasts:
Biography
Dr. Hamm, an expert on kidney diseases and hypertension, joined the Tulane faculty in 1992. He has served as Director of the Tulane Hypertension and Renal Center of Excellence and chair of the American Heart Association Council on the Kidney and Cardiovascular Disease. Dr. Hamm now serves as Senior Vice President and Dean of Tulane University's School of Medicine.
Areas of Expertise (2)
Hypertension
Nephrology
Education (1)
University of Alabama: M.D.
Affiliations (2)
- Tulane Lakeside Hospital for Women and Children
- Tulane Medical Center
Links (3)
Media Appearances (3)
Nell Nolan: Spirit of Charity, Stake out for Justice, Dark and Stormy Night, Boys Town LA
The New Orleans Advocate online
2018-11-18
During the 19th annual Spirit of Charity Award Dinner given by Spirit of Charity Foundation and held at the JW Marriott, limelight turned to Dr. L. Lee Hamm III, senior vice president and dean of the Tulane University School of Medicine. The award is given to a physician whose career began or was nurtured in the healing and teaching ward of Charity Hospital and who has made a significant contribution to medicine. The foundation continues the mission and legacy of Charity Hospital.
Tulane gets $25 million to fund research at School of Medicine
The New Orleans Advocate online
2017-09-18
The department of medicine is the largest translational research department in the School of Medicine, according to Dr. Lee Hamm, dean and senior vice president of the school.
Dr. Lee Hamm named dean of Tulane's medical school
Nola.com online
2013-06-26
Hamm, who is board-certified in internal medicine and nephrology, occupies the Harry B. Greenberg Chair of Medicine and is executive vice dean and chairman of the department of medicine. He is co-director of the Tulane Hypertension and Renal Center of Excellence, and he was the medical school's interim dean before Sachs' arrival in November 2007.
Articles (5)
Differential Network Enrichment Analysis Reveals Novel Lipid Pathways in Chronic Kidney Disease
Bioinformatics
Lee Hamm, et al.
2019 Functional enrichment testing methods can reduce data comprising hundreds of altered biomolecules to smaller sets of altered biological ‘concepts’ that help generate testable hypotheses. This study leveraged differential-network-enrichment-analysis methodology to identify and validate lipid subnetworks that potentially differentiate chronic kidney disease (CKD) by severity or progression.
Heart disease and stroke statistics—2018 update: a report from the American Heart Association
Circulation
Lee Hamm, et al.
2018 Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease Control and Prevention, the National Institutes of Health, and other government agencies, brings together in a single document the most up-to-date statistics related to heart disease, stroke, and the cardiovascular risk factors listed in the AHA’s My Life Check - Life’s Simple 7 (Figure1), which include core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure [BP], and glucose control) that contribute to cardiovascular health.
Calcium receptor signaling and citrate transport
Urolithiasis
Ryan W Walker, Shijia Zhang, Joycelynn A Coleman-Barnett, L Lee Hamm, Kathleen S Hering-Smith
2018 The calcium sensing receptor (CaSR) in the distal nephron decreases the propensity for calcium stones. Here we investigate if the apical CaSR in the proximal tubule also prevents stone formation acting via regulation of apical dicarboxylate and citrate transport. Urinary citrate, partially reabsorbed as a dicarboxylate in the proximal tubule lumen, inhibits stone formation by complexing calcium.
Fibroblast growth factor 23 and anemia in the chronic renal insufficiency cohort study
Clinical Journal of the American Society of Nephrology
Lee Hamm, et al.
2017 Anemia is an early complication of CKD that is associated with increased morbidity and mortality. Prior data show associations between abnormal mineral metabolism markers and decreased erythropoiesis. However, few studies have investigated elevated fibroblast growth factor 23 as a risk factor for the development of anemia in patients with CKD.
Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study
Journal of the American Heart Association
Lee Hamm, et al.
2017 Heart failure is common in patients with chronic kidney disease. We studied risk factors for incident heart failure among 3557 participants in the CRIC (Chronic Renal Insufficiency Cohort) Study.
Social